Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dolman

Showing results (161-170 of 165) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 165 results.
EMBO Molecular Medicine|August 2, 2022
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypesMichael T Meister, Marian J A Groot Koerkamp, Terezinha de Souza, et al.
Molecular Cancer Therapeutics|April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the YoungAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicineKarin P S Langenberg, Sander R van Hooff, Bianca Koopmans, et al.
Nature Genetics|June 30, 2015
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutationsThomas F Eleveld, Derek A Oldridge, Virginie Bernard, et al.
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
Pageof 17

Showing results (161-170 of 165) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 165 results.
EMBO Molecular Medicine|August 2, 2022
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypesMichael T Meister, Marian J A Groot Koerkamp, Terezinha de Souza, et al.
Molecular Cancer Therapeutics|April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the YoungAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicineKarin P S Langenberg, Sander R van Hooff, Bianca Koopmans, et al.
Nature Genetics|June 30, 2015
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutationsThomas F Eleveld, Derek A Oldridge, Virginie Bernard, et al.
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
Pageof 17